Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Brain, Behavior, and Immunity
|
August 11, 2015
Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies
H Maxime Lagraauw, Johan Kuiper, Ilze Bot
The Pediatric Infectious Disease Journal
|
January 13, 2023
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients
Timothy J Carrothers, H Maxime Lagraauw, Lars Lindbom, et al.
Scientific Reports
|
February 16, 2019
Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
H Maxime Lagraauw, Anouk Wezel, Daniël van der Velden, et al.
Journal of Cellular and Molecular Medicine
|
August 16, 2014
Complement factor C5a induces atherosclerotic plaque disruptions
Anouk Wezel, Margreet R de Vries, H Maxime Lagraauw, et al.
British Journal of Clinical Pharmacology
|
September 22, 2024
Exposure-response relationships of mirvetuximab soravtansine in patients with folate receptor-α-positive ovarian cancer: Justification of therapeutic dose regimen
Ya-Ping Tu, H Maxime Lagraauw, Michael Method, et al.
British Journal of Clinical Pharmacology
|
October 23, 2023
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite
Ya-Ping Tu, Eva Hanze, Fengying Zhu, et al.
Atherosclerosis
|
June 12, 2015
Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression
Anouk Wezel, H Maxime Lagraauw, Daniël van der Velden, et al.
Atherosclerosis
|
May 27, 2014
Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation
H Maxime Lagraauw, Marijke M Westra, Martine Bot, et al.
Arthritis Research & Therapy
|
June 15, 2016
Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile
Daniël van der Velden, H Maxime Lagraauw, Anouk Wezel, et al.
Atherosclerosis
|
December 9, 2014
RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner
Anouk Wezel, Daniël van der Velden, Johanna M Maassen, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Brain, Behavior, and Immunity
|
August 11, 2015
Acute and chronic psychological stress as risk factors for cardiovascular disease: Insights gained from epidemiological, clinical and experimental studies
H Maxime Lagraauw, Johan Kuiper, Ilze Bot
The Pediatric Infectious Disease Journal
|
January 13, 2023
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Target Attainment Analyses for Dalbavancin in Pediatric Patients
Timothy J Carrothers, H Maxime Lagraauw, Lars Lindbom, et al.
Scientific Reports
|
February 16, 2019
Stress-induced mast cell activation contributes to atherosclerotic plaque destabilization
H Maxime Lagraauw, Anouk Wezel, Daniël van der Velden, et al.
Journal of Cellular and Molecular Medicine
|
August 16, 2014
Complement factor C5a induces atherosclerotic plaque disruptions
Anouk Wezel, Margreet R de Vries, H Maxime Lagraauw, et al.
British Journal of Clinical Pharmacology
|
September 22, 2024
Exposure-response relationships of mirvetuximab soravtansine in patients with folate receptor-α-positive ovarian cancer: Justification of therapeutic dose regimen
Ya-Ping Tu, H Maxime Lagraauw, Michael Method, et al.
British Journal of Clinical Pharmacology
|
October 23, 2023
Population pharmacokinetics of mirvetuximab soravtansine in patients with folate receptor-α positive ovarian cancer: The antibody-drug conjugate, payload and metabolite
Ya-Ping Tu, Eva Hanze, Fengying Zhu, et al.
Atherosclerosis
|
June 12, 2015
Mast cells mediate neutrophil recruitment during atherosclerotic plaque progression
Anouk Wezel, H Maxime Lagraauw, Daniël van der Velden, et al.
Atherosclerosis
|
May 27, 2014
Vascular neuropeptide Y contributes to atherosclerotic plaque progression and perivascular mast cell activation
H Maxime Lagraauw, Marijke M Westra, Martine Bot, et al.
Arthritis Research & Therapy
|
June 15, 2016
Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile
Daniël van der Velden, H Maxime Lagraauw, Anouk Wezel, et al.
Atherosclerosis
|
December 9, 2014
RP105 deficiency attenuates early atherosclerosis via decreased monocyte influx in a CCR2 dependent manner
Anouk Wezel, Daniël van der Velden, Johanna M Maassen, et al.
Page
of 2